February 11, 2009 7:11 PM
- Text
FDA Official Quits Over Pill Delay
(AP)
A high-ranking Food and Drug Administration official resigned Wednesday in protest of the agency's refusal to allow over-the-counter sales of emergency contraception.
Susan Wood, director of FDA's Office of Women's Health, announced her resignation in an e-mail to colleagues at the agency. The e-mail was released by contraception advocates.
The FDA on Friday postponed indefinitely its decision on whether to allow the morning-after pill, called Plan B, to sell without a prescription. The agency said it was safe for adults to use without a doctor's guidance, but said young teenagers still needed a prescription and that it couldn't determine how to enforce an age limit, a decision contrary to the advice of its own scientific advisers.
"I can no longer serve as staff when scientific and clinical evidence, fully evaluated and recommended for approval by the professional staff here, has been overruled," wrote Wood, who also was assistant commissioner for women's health. "The recent decision announced by the Commissioner about emergency contraception, which continues to limit women's access to a product that would reduce unintended pregnancies and reduce abortions, is contrary to my core commitment to improving and advancing women's health."
Wood, a biologist, joined FDA's women's health office in 2000, after directing women's health programs at its parent agency, the Department of Health and Human Services. She has worked as a research scientist and a prominent congressional adviser.
FDA spokeswoman Suzanne Trevino did not immediately comment on the resignation.
The morning-after pill is a high dose of regular birth control that, taken within 72 hours of unprotected sex, can lower the risk of pregnancy by up to 89 percent.
Susan Wood, director of FDA's Office of Women's Health, announced her resignation in an e-mail to colleagues at the agency. The e-mail was released by contraception advocates.
The FDA on Friday postponed indefinitely its decision on whether to allow the morning-after pill, called Plan B, to sell without a prescription. The agency said it was safe for adults to use without a doctor's guidance, but said young teenagers still needed a prescription and that it couldn't determine how to enforce an age limit, a decision contrary to the advice of its own scientific advisers.
"I can no longer serve as staff when scientific and clinical evidence, fully evaluated and recommended for approval by the professional staff here, has been overruled," wrote Wood, who also was assistant commissioner for women's health. "The recent decision announced by the Commissioner about emergency contraception, which continues to limit women's access to a product that would reduce unintended pregnancies and reduce abortions, is contrary to my core commitment to improving and advancing women's health."
Wood, a biologist, joined FDA's women's health office in 2000, after directing women's health programs at its parent agency, the Department of Health and Human Services. She has worked as a research scientist and a prominent congressional adviser.
FDA spokeswoman Suzanne Trevino did not immediately comment on the resignation.
The morning-after pill is a high dose of regular birth control that, taken within 72 hours of unprotected sex, can lower the risk of pregnancy by up to 89 percent.
- 1
- 2
- Next Page »
Popular Now in Health
- Cancer drug reverses Alzheimer's in mice: Study
- 4.5 million Americans over 50 have artificial knees
- Marijuana-smoking motorists twice as likely to crash
- Skin cancer self-exam: What to look for (PHOTOS)
- Things You Didn't Know About Your Penis
- HealthPop: Online dating and jaw engraving
- PICTURES: 15 Shocking Sexual Fetishes
- Christina Hendricks: Too Big for Hollywood?
- John Dye Dies: What Killed "Angel" Star?
- Whitney Houston back in rehab: Why?
- Online dating downsides, romantic tattoo gone wrong: HealthPop Valentine's Day video
- Woman spotlights uterus didelphys on talk show
- 8 Tips For Losing Weight After Pregnancy
- Caffeine inhalers - the next club drug?
- Demi Moore's hospitalization spotlights whippets
- Norovirus outbreak hits Rider University in N.J
- Anti-Rape Condoms Fight World Cup Sex Assault
Latest CBS News Headlines
on Facebook Most Discussed Stories
on CBS News
- Zambia shocks Ivory Coast in African Cup final
- Red Wings match record with 20th straight home win
- Red Wings match record with 20th straight home win
- Asia stocks rise after Greece austerity vote
on Facebook Most Discussed Stories
on CBS News






